3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Research output: Contribution to journalArticlepeer-review

235 Citations (Scopus)

Fingerprint

Dive into the research topics of '3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences